Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms
Autoantibodies against leucine-rich glioma inactivated 1 (LGI1) are found in patients with limbic encephalitis and focal seizures. Here, we generate patient-derived monoclonal antibodies (mAbs) against LGI1. We explore their sequences and binding characteristics, plus their pathogenic potential usin...
Glavni autori: | Ramberger, M, Berretta, A, Tan, JMM, Sun, B, Michael, S, Yeo, T, Theorell, J, Bashford-Rogers, R, Paneva, S, O'Dowd, V, Dedi, N, Topia, S, Griffin, R, Ramirez-Franco, J, El Far, O, Baulac, S, Leite, MI, Sen, A, Jeans, A, McMillan, D, Marshall, D, Anthony, D, Lightwood, D, Waters, P, Irani, SR |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Oxford University Press
2020
|
Slični predmeti
-
CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
od: Michael, S, i dr.
Izdano: (2019) -
CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
od: Michael, S, i dr.
Izdano: (2019) -
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
od: Michael, S, i dr.
Izdano: (2020) -
An epitope-specific LGI1-autoantibody enhances neuronal excitability by modulating Kv1.1 channel
od: Extrémet, J, i dr.
Izdano: (2022) -
Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
od: Dubey, D, i dr.
Izdano: (2019)